A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma.
Ann Oncol
; 27(4): 680-7, 2016 Apr.
Article
in En
| MEDLINE
| ID: mdl-26802147
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Niacinamide
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2016
Document type:
Article
Affiliation country:
Romania